ACTO Earns Gold at Brandon Hall Technology Awards 2021

Toronto, Ontario (December 15, 2021) –  ACTO, the creator of the innovative Omnichannel Education Platform for Life Sciences, today announced it won a coveted Brandon Hall Group Gold award for excellence in Best Advance in Learning Management Measurement/Business Impact Tools. The award is for Digitally Transforming the Life Sciences Industry with Omnichannel Education. ACTO’s technology uses AI-powered mobile experiences to …

Implementation Blueprint for Omnichannel Education

You may have been hearing the buzz around “Omnichannel Education” repeated within the life sciences industry. As we are adapting to how the world is changing, we must also adapt to how our employees learn. This is where Omnichannel Education comes into play.  During the Life Sciences Trainers and Educators Network’s Annual Conference (LTEN), ACTO had the opportunity to educate …

ACTO Kicks Off 2021 with Chart-Topping Growth

Life sciences tech leader triples headcount, announces 5X ARR boost TORONTO, Jan. 28, 2021 /PRNewswire/ – ACTO, the Omnichannel Education Platform for Life Sciences, today announced major growth across a range of key metrics during 2020, including a 500% increase in annual recurring revenue since 2018. During the global pandemic, ACTO has cemented its position as an essential partner for life sciences …

ACTO Acquires Scrimmage, Disrupting Life Sciences Learning and Engagement Market

TORONTO, Sept. 10, 2020 /PRNewswire/ – ACTO, the leading omnichannel education and engagement platform for life sciences, today announced its acquisition of Scrimmage, a pioneering mobile learning provider. Following ACTO’s $11.5M Series A round, the acquisition establishes ACTO as a life sciences SaaS leader with an unparalleled portfolio of 100+ clients, including seven of the top 20 pharma companies and six of the top …

ACTO Closes $11.5M Series A Round to Accelerate Virtual Transformation for Life Sciences Companies

TORONTO, Aug. 27, 2020 /PRNewswire/ – ACTO, the omnichannel education and engagement platform for life sciences, today announced the closing of a $11.5 million Series A round led by Resolve Growth Partners, a Baltimore-based growth equity firm focused on software entrepreneurs. The round also includes strategic funding from new investor Salesforce Ventures, as well as follow-on investment from existing investor Panache Ventures. ACTO is a …

ACTO Achieves 158% Year to Date Revenue Growth in 2019 and Has Digitally Transformed Over 50 Life Sciences Companies

TORONTO, Dec. 5, 2019 /CNW/ – ACTO achieved 158% year to date revenue growth and has digitally transformed over 50 life sciences companies, including global pharma, medical device, and dental companies. Since its launch one year ago, the ACTO Commercialization Cloud for Life Sciences has digitally transformed companies such as AstraZeneca, Teleflex, and Philips Respironics, enabling their field force to promote on …

eyeforpharma Awards Recognize Two ACTO Use Cases as Finalists

TORONTO, Nov. 25, 2019 /CNW/ – Two of ACTO’s use cases have been nominated as finalists in the eyeforpharma Awards, which focus on recognizing genuine, truly innovative and meaningful approaches to excellence in the pharmaceutical industry. AstraZeneca has been nominated in the ‘Most Promising MVP/Pilot’ category for its ACTO use case. ACTO has been nominated in the ‘Most Valuable Data & Insights …